The first MICCAI challenge on PET tumor segmentation
Positron Emission Tomography (PET) / Computed Tomography (CT) is established today as an important tool for patients management in oncology, cardiology and neurology. In oncology especially, fluorodeoxyglucose (FDG) PET is routinely used for diagnosis, staging, radiotherapy planning, and therapy monitoring and follow-up (Bai et al., 2013). After data acquisition and image reconstruction, an important step for exploiting the quantitative content of PET/CT images is the region of interest (ROI) determination that allows extracting semi-quantitative metrics such as mean or maximum standardized uptake values (SUV).
Source: Medical Image Analysis - Category: Radiology Authors: Mathieu Hatt, Baptiste Laurent, Anouar Ouahabi, Hadi Fayad, Shan Tan, Laquan Li, Wei Lu, Vincent Jaouen, Clovis Tauber, Jakub Czakon, Filip Drapejkowski, Witold Dyrka, Sorina Camarasu-Pop, Fr édéric Cervenansky, Pascal Girard, Tristan Glatard, Michael K Source Type: research
More News: Brain | Cancer & Oncology | Cardiology | CT Scan | Heart | Mergers and Aquisitions | Neurology | PET Scan | Radiology